Mitotic Rate in Cutaneous Melanomas ≤1 mm in Thickness: A Prospective Study

被引:11
|
作者
Litzner, Brandon R. [1 ]
Etufugh, Chukwuemeka N. [2 ]
Stepenaskie, Shelly [3 ]
Hynan, Linda S. [4 ]
Cockerell, Clay J. [1 ,5 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA
[2] Greater Dallas Pathol, Dallas, TX USA
[3] Univ New Mexico, Dept Dermatol, Albuquerque, NM 87131 USA
[4] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Div Biostat, Dallas, TX 75390 USA
[5] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
关键词
mitotic rate; thin melanoma; melanoma; hot-spot technique; Sentinel Lymph Node Biopsy; LYMPH-NODE BIOPSY; PROGNOSTIC IMPORTANCE; MALIGNANT-MELANOMA; RECURRENCE; PREDICTORS; HISTOLOGY; SURVIVAL; PATTERNS;
D O I
10.1097/DAD.0b013e3182604d96
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The mitotic rate (MR) of malignant melanoma (MM) refers to the number of mitoses per square millimeter. Studies have suggested that it is an independent prognostic variable predicting survival in patients with MM, and it was recently included in the American Joint Committee on Cancer (AJCC) recommendations for diagnosis and treatment of MM. The AJCC melanoma staging committee recommends using the "hot-spot" approach to determine the MR, whereby it is reported as the maximum dermal mitotic figures identified in a 1-mm(2) area of the melanoma. The AJCC has recommended that the MR be determined in all melanomas, irrespective of Breslow depth or other features. We aimed to quantify the MR in MM <= 1 mm in thickness and to identify statistical associations between the MR, Breslow depth, and Clark level. In addition, we hoped to identify practical issues in determining the MR via the hot-spot technique. We conducted a prospective study to determine the MR, Breslow depth, and Clark level in MM <= 1 mm in thickness. Seven melanomas were identified with epidermal mitoses only (7.4%). Sixteen melanomas had dermal mitoses (16.8%); of these, the majority (75.0%) contained only one mitotic figure. Seventy-nine melanomas had no dermal mitoses (83.2%). Seven lesions (7.4%) demonstrated multiple mitoses; 4 with >= 2 dermal mitoses/mm(2) and 3 with multiple epidermal mitoses. We conclude that thin MM with >1 mitosis/mm(2) is rare and discuss practical and theoretical issues with determining the MR using the hot-spot approach.
引用
收藏
页码:827 / 832
页数:6
相关论文
共 50 条
  • [1] Assessment of tumor mitotic rate in primary cutaneous malignant melanomas 1 mm or less in thickness
    Shin, Christina
    Tallon, Ben
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (03) : 405 - 409
  • [2] Prospective epidemiological study on cutaneous melanomas in the Vendee area
    Brisson, C
    Reynaud-Hautin, C
    Bure, E
    Chatal, M
    Hadet-Riegert, M
    Rafstedt, P
    Humeau, S
    Kerangueven, J
    Leroux, E
    Legroux, J
    Martin, MP
    Nogues, M
    Remond, L
    Ottavy, N
    Thebaud, Y
    Patarin, M
    Clement, A
    Proux, M
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2003, 130 (12): : 1121 - 1124
  • [3] Prospective clinical study on new cutaneous melanomas in the Vendee area
    Brisson, C
    Reynaud-Hautin, C
    Bure, E
    Chatal, M
    Hadet-Riegert, M
    Rafstedt, P
    Humeau, S
    Kerangueven, J
    Leroux, E
    Legroux, J
    Martin, MP
    Nogues, M
    Remond, L
    Ottavy, N
    Thebaud, Y
    Patarin, M
    Clement, A
    Proux, M
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2003, 130 (12): : 1125 - 1128
  • [4] The role of phosphohistone H3 immunostaining (pHH3) as a mitotic rate marker in cutaneous melanomas with Breslow Index greater than 1.0 mm
    Rompoti, N.
    Schimming, T.
    Livingstone, E.
    Schadendorf, D.
    Hillen, U.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 76 - 77
  • [5] Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1–2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center
    Lauren E. Haydu
    Joram T. Stollman
    Richard A. Scolyer
    Andrew J. Spillane
    Michael J. Quinn
    Robyn P. M. Saw
    Kerwin F. Shannon
    Jonathan R. Stretch
    Johannes J. Bonenkamp
    John F. Thompson
    Annals of Surgical Oncology, 2016, 23 : 1071 - 1081
  • [6] EVOLUTION OF MELANOMAS WITH A THICKNESS LESSER THAN 0.76MM
    MAGNIN, PH
    BELLINCIONI, NS
    CASAS, JG
    PRENSA MEDICA ARGENTINA, 1986, 73 (02): : 60 - 62
  • [7] THE KI-67 ANTIGEN IN PRIMARY HUMAN MELANOMAS - ITS RELATIONSHIP TO MITOTIC RATE AND TUMOR THICKNESS AND ITS STABILITY
    OSTMEIER, H
    SUTER, L
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1989, 281 (03) : 173 - 177
  • [8] Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center
    Haydu, Lauren E.
    Stollman, Joram T.
    Scolyer, Richard A.
    Spillane, Andrew J.
    Quinn, Michael J.
    Saw, Robyn P. M.
    Shannon, Kerwin F.
    Stretch, Jonathan R.
    Bonenkamp, Johannes J.
    Thompson, John F.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (04) : 1071 - 1081
  • [9] Mitotic rate is associated with positive lymph nodes in patients with thin melanomas
    Wheless, Lee
    Isom, Chelsea A.
    Hooks, Mary A.
    Kauffmann, Rondi M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (05) : 935 - 941
  • [10] Mitotic Rate as a Predictor of Sentinel Lymph NodePositivity in Patients With Thin Melanomas
    Susan B. Kesmodel
    Giorgos C. Karakousis
    Jeffrey D. Botbyl
    Robert J. Canter
    Robert T. Lewis
    Peter M. Wahl
    Kyla P. Terhune
    Abass Alavi
    David E. Elder
    Michael E. Ming
    DuPont Guerry
    Phyllis A. Gimotty
    Douglas L. Fraker
    Brian J. Czerniecki
    Francis R. Spitz
    Annals of Surgical Oncology, 2005, 12 : 449 - 458